| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/25/2003 | US20030180714 Shotgun scanning |
| 09/25/2003 | US20030180713 Contacting a first cell with the compound, determining a first value of a property of the first cell, contacting second cell containing zinc finger protein which modulates expression of the molecular target, determining second value of the cell |
| 09/25/2003 | US20030180712 Host cells transfected with a recombinant expression vector containing nucleic acid control sequences operatively linked to an L-type Ca2+ channel beta 3 gene; host cell free of functional beta 3 subunit-containing L-type Ca2+ channels |
| 09/25/2003 | US20030180708 Quick and sensitive method of quantifying mycolic acid to develop anti-microbial agents and a diagnostic kit thereof |
| 09/25/2003 | US20030180707 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site |
| 09/25/2003 | US20030180706 Removal of prions from blood, plasma and other liquids |
| 09/25/2003 | US20030180441 Thin film overcoating electrode; biosensor |
| 09/25/2003 | US20030180396 Central nervous system disorders; screening for allergens |
| 09/25/2003 | US20030180391 Berberine, baicalein; plant extracts; side effect reduction |
| 09/25/2003 | US20030180328 Forming vaccines; analyzing hemagglutinin, calibration |
| 09/25/2003 | US20030180327 Veterinary medicine; induce immunology response |
| 09/25/2003 | US20030180326 Methods and compositions for impairing multiplication of HIV-1 |
| 09/25/2003 | US20030180324 Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use |
| 09/25/2003 | US20030180323 Diagnosis, prevention and treatment of calicivirus infection in humans |
| 09/25/2003 | US20030180317 Diagnosis ear infections in children |
| 09/25/2003 | US20030180315 Novel proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 09/25/2003 | US20030180313 Genetic engineering; detection of humans immunodeficiency virus infections |
| 09/25/2003 | US20030180311 Genetic engineering; binding to antibodies; drugs, medical diagnosis, biosensors |
| 09/25/2003 | US20030180307 Polypeptides; detecting infections using antibodies |
| 09/25/2003 | US20030180304 Enzyme inhibitor; tuberculosis therapy |
| 09/25/2003 | US20030180300 Collagen biosynthesis; controlling cell differentiation, cell proliferation |
| 09/25/2003 | US20030180298 Genetic engineering; using nucleic acid for cancer diagnosis |
| 09/25/2003 | US20030180295 Angiocidin: a Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 09/25/2003 | US20030180287 Polypeptide formulation |
| 09/25/2003 | US20030180285 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti hsp90 antibodies |
| 09/25/2003 | US20030180284 Monoclonal antibodies; vaccines |
| 09/25/2003 | US20030180280 Calibration deafness therapy; administering mixture of protein and carrier |
| 09/25/2003 | US20030180275 Human serpin polypeptides |
| 09/25/2003 | US20030180225 Walnut and ryegrass allergens |
| 09/25/2003 | US20030180219 Calibrating efficiency of vaccines |
| 09/25/2003 | US20030180218 Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents |
| 09/25/2003 | US20030180187 Air pollution control; using absorbers |
| 09/25/2003 | US20030180186 Measuring electroconductivity, temperature of water streams; calibration; electrolysis of water |
| 09/25/2003 | US20030180184 Chemical sensor device |
| 09/25/2003 | US20030180183 Forming reaction product; coloimetric analysis |
| 09/25/2003 | US20030180182 Dry analytical element that avoids influence of globulin |
| 09/25/2003 | US20030179916 High-throughput cell identification and isolation method and apparatus |
| 09/25/2003 | US20030179002 Oil quality measurement device |
| 09/25/2003 | US20030178641 Microfluidic platforms for use with specific binding assays, specific binding assays that employ microfluidics, and methods |
| 09/25/2003 | US20030178589 Isotopic gas analyzer and method of judging absorption capacity of carbon dioxide absornemt |
| 09/25/2003 | US20030178569 Pathlength-independent methods for optically determining material composition |
| 09/25/2003 | US20030178323 For measuring sulfur oxide content in wine; electrolytic cells |
| 09/25/2003 | US20030178309 Multiple-property composite beads and preparation and use thereof |
| 09/25/2003 | US20030178304 Carbon dioxide sensor and method of determining partial pressure of carbon dioxide |
| 09/25/2003 | US20030177851 Sensor head apparatus |
| 09/25/2003 | US20030177834 Liquefaction phenomenon prediction system |
| 09/25/2003 | US20030177815 Pellet resistor sensor |
| 09/25/2003 | DE20306476U1 Diagnostic test formulation for determination of protein in body fluids, especially urine, containing disaccharide and water-soluble synthetic polymer as stabilizers |
| 09/25/2003 | CA2480827A1 Apparatus and method for determining a person's sobriety |
| 09/25/2003 | CA2478986A1 Method of identifying genes controlling differentiation |
| 09/25/2003 | CA2478964A1 Integrated system for high throughput capture of genetic diversity |
| 09/25/2003 | CA2478962A1 Cell surface tropomyosin as a target of angiogenesis inhibition |
| 09/25/2003 | CA2478881A1 Methods to increase nucleotide signals by raman scattering |
| 09/25/2003 | CA2478878A1 Identifying peptide modifications |
| 09/25/2003 | CA2478850A1 Gene expression profiling in biopsied tumor tissues |
| 09/25/2003 | CA2478808A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders |
| 09/25/2003 | CA2478790A1 Polypeptides binding to human syntaxin 1a |
| 09/25/2003 | CA2478699A1 Immunoassays for .beta.2-microglobulin |
| 09/25/2003 | CA2478668A1 Improved method for on-line monitoring of lubricating oil using light in the visible and near ir spectra |
| 09/25/2003 | CA2477909A1 Novel metabolic targets and markers |
| 09/25/2003 | CA2477765A1 System and method for determining fouling tendency by refinery feed stocks |
| 09/25/2003 | CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/25/2003 | CA2454368A1 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
| 09/24/2003 | EP1347493A2 Method and apparatus for desorption and ionization of analytes |
| 09/24/2003 | EP1347463A2 Novel electrically conductive polymer, sensor using the same, and method for detecting target molecule using the sensor |
| 09/24/2003 | EP1347302A2 Direct immunosensor assay |
| 09/24/2003 | EP1347301A1 Method for ultra-rapid and ultra-sensitive measurement |
| 09/24/2003 | EP1347300A1 Method of measuring binding activity of ligand-binding protein having poor chemical stability to first ligand |
| 09/24/2003 | EP1347299A1 Specific bonding analysis method and specific bonding analysis device using it |
| 09/24/2003 | EP1347298A2 Immunoassay method, test strip for use therein, and immunoassay apparatus |
| 09/24/2003 | EP1347297A1 Method of reusing dna-immobilization substrate |
| 09/24/2003 | EP1347296A2 Storage cartridge for biosensors |
| 09/24/2003 | EP1347295A1 Method for detecting or quantitatively determining Natural bitumen in an asphalt sample |
| 09/24/2003 | EP1347292A1 Biosensor |
| 09/24/2003 | EP1347291A1 Flaw detector |
| 09/24/2003 | EP1347285A1 Method and apparatus for measuring fluorescence luminance |
| 09/24/2003 | EP1347283A2 Device and method for determining inhomogeneities in material webs |
| 09/24/2003 | EP1347059A1 Cathepsin Y for the development of a medicament for the treatment of stroke |
| 09/24/2003 | EP1347058A2 Electrochemical biosensor with connector windows |
| 09/24/2003 | EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 09/24/2003 | EP1347051A1 Method of examining allergic disease |
| 09/24/2003 | EP1347050A1 Novel potassium channel |
| 09/24/2003 | EP1347048A1 Novel protease |
| 09/24/2003 | EP1346999A2 Human secreted protein |
| 09/24/2003 | EP1346773A2 Apparatus and method for separating a biological sample |
| 09/24/2003 | EP1346730A1 Pretargeting methods and novel pretargeting conjugates |
| 09/24/2003 | EP1346692A1 Swab testing device and method |
| 09/24/2003 | EP1346683A2 Procedure, apparatus and sensor for the determination of fractional oxygen saturation |
| 09/24/2003 | EP1346230A2 Screening method based on tsap6 binding partners |
| 09/24/2003 | EP1346229A2 Inverse labeling method for the rapid identification of marker/target proteins |
| 09/24/2003 | EP1346228A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 09/24/2003 | EP1346227A1 Detection of advanced glycation endproducts in a cerebrospinal fluid sample |
| 09/24/2003 | EP1346226A1 Screening method based on siah-numb interaction |
| 09/24/2003 | EP1346225A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 09/24/2003 | EP1346224A1 Method and device for the manipulation of microcarriers for an identification purpose |
| 09/24/2003 | EP1346223A2 Reagent for luminescence optical determination of an analyte |
| 09/24/2003 | EP1346222A1 Attachment of second harmonic-active moiety to molecules for detection of molecules at interfaces |
| 09/24/2003 | EP1346221A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 09/24/2003 | EP1346220A2 Sensor for luminescence optical determination of an analyte |
| 09/24/2003 | EP1346219A1 Analytic method and reagent for use thereof |